Saroglitazar Drug News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Saroglitazar drug. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Saroglitazar Drug Today - Breaking & Trending Today

Torrent, Zydus in co-marketing pact for liver disease drug Saroglitazar

Torrent Pharmaceuticals and Zydus Lifesciences formed a licensing and supply pact to co-market Saroglitazar Mg, the sole approved treatment for Non-Alcoholic Steato Hepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD) in India. Under the agreement, Torrent gains semi-exclusive rights to market as VORXAR while Zydus continues marketing as Lipaglyn and Bilypsa. Licensing fees and milestone payments are part of the pact. ....

Zydus Lifescieces , Sharvil Patel , Zydus Lifesciences , Raman Mehta , Torrent Pharmaceuticals , Non Alcoholic Steato Hepatitis , Non Alcoholic Fatty Liver Disease , Saroglitazar Magnesium , Saroglitazar Drug ,